These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12951361)

  • 1. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
    Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
    J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
    Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
    J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux.
    Yancey PG; Kawashiri MA; Moore R; Glick JM; Williams DL; Connelly MA; Rader DJ; Rothblat GH
    J Lipid Res; 2004 Feb; 45(2):337-46. PubMed ID: 14594995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ABCA1 activity protects against atherosclerosis.
    Singaraja RR; Fievet C; Castro G; James ER; Hennuyer N; Clee SM; Bissada N; Choy JC; Fruchart JC; McManus BM; Staels B; Hayden MR
    J Clin Invest; 2002 Jul; 110(1):35-42. PubMed ID: 12093886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
    Lorenzi I; von Eckardstein A; Cavelier C; Radosavljevic S; Rohrer L
    J Mol Med (Berl); 2008 Feb; 86(2):171-83. PubMed ID: 17906976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
    Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
    Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
    J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.
    Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR
    J Clin Invest; 2007 Dec; 117(12):3900-8. PubMed ID: 17992262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.
    Zannis VI; Chroni A; Kypreos KE; Kan HY; Cesar TB; Zanni EE; Kardassis D
    Curr Opin Lipidol; 2004 Apr; 15(2):151-66. PubMed ID: 15017358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.
    Yue P; Chen Z; Nassir F; Bernal-Mizrachi C; Finck B; Azhar S; Abumrad NA
    PLoS One; 2010 Mar; 5(3):e9906. PubMed ID: 20360851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.
    Nandi S; Ma L; Denis M; Karwatsky J; Li Z; Jiang XC; Zha X
    J Lipid Res; 2009 Mar; 50(3):456-466. PubMed ID: 18941142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
    Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
    Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
    Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
    Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
    Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.